@Rykster I am invested in RECCE since a week and would definitely be interested on hearing your justification on "certainly better than a failure, just nowhere near the 'company maker' that some seem to think"
so easy to type those few words with misplaced arrogance....please now show what your posts are worth.
certainly better than a failure: why? what could they have done better than being successful in all patients...
nowhere near the 'company maker' that some seem to think: why? a new treatment that can be used for antibiotic resistant infections, not company maker...
here's your chance...worthless or critical investor with comprehensible arguments.
(20min delay)